Anne Cayre
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab(2008)1,450 cited
- → Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer(2009)665 cited
- → Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network(2013)315 cited
- → Does inhibition of P-glycoprotein lead to drug–drug interactions?(2005)169 cited
- → Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact(2014)122 cited
- → Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study(2012)91 cited
- → aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer(2003)91 cited
- → Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome(2003)84 cited
- → BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells(2014)83 cited
- → Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy(2008)72 cited